Sign In

Login

Password

Forgot Password ? Sign Up

تدبير قصور القلب (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "تدبير قصور القلب" in Arabic language version.

refsWebsite
Global rank Arabic rank
22nih.gov
4th place
6th place
16doi.org
2nd place
5th place
2archive.org
6th place
3rd place
1worldcat.org
5th place
4th place
1nice.org.uk
3,258th place
1,371st place
1web.archive.org
1st place
1st place

archive.org

doi.org

  • Chaudhry SI، وآخرون (2007). "Patterns of Weight Change Preceding Hospitalization for Heart Failure". Circulation. ج. 116 ع. 14: 1549–54. DOI:10.1161/CIRCULATIONAHA.107.690768. PMC:2892745. PMID:17846286.
  • Packer M (1989). "Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure". Am. J. Cardiol. ج. 63 ع. 2: 41A–45A. DOI:10.1016/0002-9149(89)90392-5. PMID:2642629.
  • Packer M، Carver JR، Rodeheffer RJ، وآخرون (1991). "Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group". N. Engl. J. Med. ج. 325 ع. 21: 1468–75. DOI:10.1056/NEJM199111213252103. PMID:1944425.
  • Hunt SA، Abraham WT، Chin MH، وآخرون (2005). "ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult". Circulation. ج. 112 ع. 12: e154–235. DOI:10.1161/CIRCULATIONAHA.105.167586. PMID:16160202.
  • Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. (2003). "Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial". Lancet. ج. 362 ع. 9386: 772–76. DOI:10.1016/S0140-6736(03)14284-5. PMID:13678870.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: أسماء متعددة: قائمة المؤلفين (link)
  • Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S; CHARM Investigators and Committees. (2003). "Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme". Lancet. ج. 362 ع. 9386: 759–66. DOI:10.1016/S0140-6736(03)14282-1. PMID:13678868.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: أسماء متعددة: قائمة المؤلفين (link)
  • McMurray JJ, Ostergren J, Swedberg K, Granger CB, Michelson EL, Olofssun B, Yusuf S, Pfeffer, MA; CHARM Investigators and Committees. (2003). "Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Added trial". Lancet. ج. 362 ع. 9386: 767–71. DOI:10.1016/S0140-6736(03)14283-3. PMID:13678869.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: أسماء متعددة: قائمة المؤلفين (link)
  • Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. (2001). "A randomized trial of the angiotensin-recepto blocker valsartan in chronic heart failure". N Engl J Med. ج. 345 ع. 23: 1667–75. DOI:10.1056/NEJMoa010713. PMID:11759645.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: أسماء متعددة: قائمة المؤلفين (link)
  • Heran BS، Musini VM، Bassett K، Taylor RS، Wright JM (2012). "Angiotensin receptor blockers for heart failure". Cochrane Database of Systematic Reviews. ج. 4 ع. 23: CD003040. DOI:10.1002/14651858.CD003040.pub2. PMC:6823214. PMID:22513909.
  • RADO، JP؛ BLUMENFELD, G؛ HAMMER, S (نوفمبر 1959). "The effect of prednisone and 6-methylprednisolone on mercurial diuresis in patients with refractory cardiac edema". The American Journal of the Medical Sciences. ج. 238: 542–51. DOI:10.1097/00000441-195911000-00003. PMID:14435747.
  • RIEMER، AD (أبريل 1958). "Application of the newer corticosteroids to augment diuresis in congestive heart failure". The American Journal of Cardiology. ج. 1 ع. 4: 488–96. DOI:10.1016/0002-9149(58)90120-6. PMID:13520608.
  • Zhang، H؛ Liu, C؛ Ji, Z؛ Liu, G؛ Zhao, Q؛ Ao, YG؛ Wang, L؛ Deng, B؛ Zhen, Y؛ Tian, L؛ Ji, L؛ Liu, K (سبتمبر 2008). "Prednisone adding to usual care treatment for refractory decompensated congestive heart failure". International Heart Journal. ج. 49 ع. 5: 587–95. DOI:10.1536/ihj.49.587. PMID:18971570.
  • Liu، C؛ Liu, G؛ Zhou, C؛ Ji, Z؛ Zhen, Y؛ Liu, K (سبتمبر 2007). "Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance". The Canadian Journal of Cardiology. ج. 23 ع. 11: 865–68. DOI:10.1016/s0828-282x(07)70840-1. PMC:2651362. PMID:17876376.
  • Liu، C؛ Chen, H؛ Zhou, C؛ Ji, Z؛ Liu, G؛ Gao, Y؛ Tian, L؛ Yao, L؛ Zheng, Y؛ Zhao, Q؛ Liu, K (أكتوبر 2006). "Potent potentiating diuretic effects of prednisone in congestive heart failure". Journal of Cardiovascular Pharmacology. ج. 48 ع. 4: 173–76. DOI:10.1097/01.fjc.0000245242.57088.5b. PMID:17086096.
  • Massari، F؛ Mastropasqua, F؛ Iacoviello, M؛ Nuzzolese, V؛ Torres, D؛ Parrinello, G (مارس 2012). "The glucocorticoid in acute decompensated heart failure: Dr Jekyll or Mr Hyde?". The American Journal of Emergency Medicine. ج. 30 ع. 3: 517.e5–10. DOI:10.1016/j.ajem.2011.01.023. PMID:21406321.
  • Liu، C؛ Chen, Y؛ Kang, Y؛ Ni, Z؛ Xiu, H؛ Guan, J؛ Liu, K (أكتوبر 2011). "Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure". The Journal of Pharmacology and Experimental Therapeutics. ج. 339 ع. 1: 203–09. DOI:10.1124/jpet.111.184796. PMID:21737535.

nice.org.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Chaudhry SI، وآخرون (2007). "Patterns of Weight Change Preceding Hospitalization for Heart Failure". Circulation. ج. 116 ع. 14: 1549–54. DOI:10.1161/CIRCULATIONAHA.107.690768. PMC:2892745. PMID:17846286.
  • Tai MK (Oct 2009). "[Evidence-based practice of fluid restriction in patients with heart failure]". Hu Li Za Zhi (بالصينية). 56 (5): 23–29. PMID:19760574.
  • Packer M (1989). "Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure". Am. J. Cardiol. ج. 63 ع. 2: 41A–45A. DOI:10.1016/0002-9149(89)90392-5. PMID:2642629.
  • Packer M، Carver JR، Rodeheffer RJ، وآخرون (1991). "Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group". N. Engl. J. Med. ج. 325 ع. 21: 1468–75. DOI:10.1056/NEJM199111213252103. PMID:1944425.
  • Hunt SA، Abraham WT، Chin MH، وآخرون (2005). "ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult". Circulation. ج. 112 ع. 12: e154–235. DOI:10.1161/CIRCULATIONAHA.105.167586. PMID:16160202.
  • Krum H, National Heart Foundation of Australia and Cardiac Society of Australia & New Zealand Chronic Heart Failure Clinical Practice Guidelines Writing Panel. (2001). "Guidelines for management of patients with chronic heart failure in Australia". Med J Aust. ج. 174 ع. 9: 459–66. PMID:11386592.
  • Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. (2003). "Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial". Lancet. ج. 362 ع. 9386: 772–76. DOI:10.1016/S0140-6736(03)14284-5. PMID:13678870.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: أسماء متعددة: قائمة المؤلفين (link)
  • Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S; CHARM Investigators and Committees. (2003). "Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme". Lancet. ج. 362 ع. 9386: 759–66. DOI:10.1016/S0140-6736(03)14282-1. PMID:13678868.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: أسماء متعددة: قائمة المؤلفين (link)
  • McMurray JJ, Ostergren J, Swedberg K, Granger CB, Michelson EL, Olofssun B, Yusuf S, Pfeffer, MA; CHARM Investigators and Committees. (2003). "Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Added trial". Lancet. ج. 362 ع. 9386: 767–71. DOI:10.1016/S0140-6736(03)14283-3. PMID:13678869.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: أسماء متعددة: قائمة المؤلفين (link)
  • Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. (2001). "A randomized trial of the angiotensin-recepto blocker valsartan in chronic heart failure". N Engl J Med. ج. 345 ع. 23: 1667–75. DOI:10.1056/NEJMoa010713. PMID:11759645.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: أسماء متعددة: قائمة المؤلفين (link)
  • Heran BS، Musini VM، Bassett K، Taylor RS، Wright JM (2012). "Angiotensin receptor blockers for heart failure". Cochrane Database of Systematic Reviews. ج. 4 ع. 23: CD003040. DOI:10.1002/14651858.CD003040.pub2. PMC:6823214. PMID:22513909.
  • RADO، JP؛ BLUMENFELD, G؛ HAMMER, S (نوفمبر 1959). "The effect of prednisone and 6-methylprednisolone on mercurial diuresis in patients with refractory cardiac edema". The American Journal of the Medical Sciences. ج. 238: 542–51. DOI:10.1097/00000441-195911000-00003. PMID:14435747.
  • RIEMER، AD (أبريل 1958). "Application of the newer corticosteroids to augment diuresis in congestive heart failure". The American Journal of Cardiology. ج. 1 ع. 4: 488–96. DOI:10.1016/0002-9149(58)90120-6. PMID:13520608.
  • NEWMAN، DA (15 فبراير 1959). "Reversal of intractable cardiac edema with prednisone". New York State Journal of Medicine. ج. 59 ع. 4: 625–33. PMID:13632954.
  • Zhang، H؛ Liu, C؛ Ji, Z؛ Liu, G؛ Zhao, Q؛ Ao, YG؛ Wang, L؛ Deng, B؛ Zhen, Y؛ Tian, L؛ Ji, L؛ Liu, K (سبتمبر 2008). "Prednisone adding to usual care treatment for refractory decompensated congestive heart failure". International Heart Journal. ج. 49 ع. 5: 587–95. DOI:10.1536/ihj.49.587. PMID:18971570.
  • Liu، C؛ Liu, G؛ Zhou, C؛ Ji, Z؛ Zhen, Y؛ Liu, K (سبتمبر 2007). "Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance". The Canadian Journal of Cardiology. ج. 23 ع. 11: 865–68. DOI:10.1016/s0828-282x(07)70840-1. PMC:2651362. PMID:17876376.
  • Liu، C؛ Chen, H؛ Zhou, C؛ Ji, Z؛ Liu, G؛ Gao, Y؛ Tian, L؛ Yao, L؛ Zheng, Y؛ Zhao, Q؛ Liu, K (أكتوبر 2006). "Potent potentiating diuretic effects of prednisone in congestive heart failure". Journal of Cardiovascular Pharmacology. ج. 48 ع. 4: 173–76. DOI:10.1097/01.fjc.0000245242.57088.5b. PMID:17086096.
  • Massari، F؛ Mastropasqua, F؛ Iacoviello, M؛ Nuzzolese, V؛ Torres, D؛ Parrinello, G (مارس 2012). "The glucocorticoid in acute decompensated heart failure: Dr Jekyll or Mr Hyde?". The American Journal of Emergency Medicine. ج. 30 ع. 3: 517.e5–10. DOI:10.1016/j.ajem.2011.01.023. PMID:21406321.
  • Liu، C؛ Chen, Y؛ Kang, Y؛ Ni, Z؛ Xiu, H؛ Guan, J؛ Liu, K (أكتوبر 2011). "Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure". The Journal of Pharmacology and Experimental Therapeutics. ج. 339 ع. 1: 203–09. DOI:10.1124/jpet.111.184796. PMID:21737535.

ncbi.nlm.nih.gov

  • Chaudhry SI، وآخرون (2007). "Patterns of Weight Change Preceding Hospitalization for Heart Failure". Circulation. ج. 116 ع. 14: 1549–54. DOI:10.1161/CIRCULATIONAHA.107.690768. PMC:2892745. PMID:17846286.
  • Heran BS، Musini VM، Bassett K، Taylor RS، Wright JM (2012). "Angiotensin receptor blockers for heart failure". Cochrane Database of Systematic Reviews. ج. 4 ع. 23: CD003040. DOI:10.1002/14651858.CD003040.pub2. PMC:6823214. PMID:22513909.
  • Liu، C؛ Liu, G؛ Zhou, C؛ Ji, Z؛ Zhen, Y؛ Liu, K (سبتمبر 2007). "Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance". The Canadian Journal of Cardiology. ج. 23 ع. 11: 865–68. DOI:10.1016/s0828-282x(07)70840-1. PMC:2651362. PMID:17876376.

web.archive.org

worldcat.org

  • Smith A, Aylward P, Campbell T, et al. Therapeutic Guidelines: Cardiovascular, 4th edition. North Melbourne: Therapeutic Guidelines; 2003. ISSN 1327-9513